Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Colfax Corporation in connection with the acquisition of the GCE Group
Mandate

Vinge has advised Colfax Corporation in connection with the acquisition of the GCE Group

August 06, 2018 M&A

GCE is Europe's leading gas equipment company with, inter alia, pressure regulators and welding nozzles in its product portfolio.

The GCE Group headquarters are located in Malmö (Sweden) and the group conducts business in over 15 countries. The main production sites are located in the Czech Republic and China. 

The transaction is subject to approval by relevant competition authorities.

Vinge’s team consisted primarily of Daniel Rosvall, Ulrich Ziche, Peter Issa, Stina Bengtsson, Elisabeth Hallberg, Ludvig Wettergren, Agnes Perbo, Sebastian Frisk, Christina Odengran, Hedvig Ekdahl, Hayaat Ibrahim, Sophia Holm, Sarah Berger, Malin Malm Waerme and Nicklas Thorgerzon.

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026